TrialAnnals of surgical oncology2023

A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032).

Areeba Saif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.